An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers
- PMID: 38547779
- PMCID: PMC11060915
- DOI: 10.1016/j.oraloncology.2024.106750
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers
Abstract
Purpose: The prognostic and predictive significance of pathologist-read tumor infiltrating lymphocytes (TILs) in head and neck cancers have been demonstrated through multiple studies over the years. TILs have not been broadly adopted clinically, perhaps due to substantial inter-observer variability. In this study, we developed a machine-based algorithm for TIL evaluation in head and neck cancers and validated its prognostic value in independent cohorts.
Experimental design: A network classifier called NN3-17 was trained to identify and calculate tumor cells, lymphocytes, fibroblasts and "other" cells on hematoxylin-eosin stained sections using the QuPath software. These measurements were used to construct three predefined TIL variables. A retrospective collection of 154 head and neck squamous cell cancer cases was used as the discovery set to identify optimal association of TIL variables and survival. Two independent cohorts of 234 cases were used for validation.
Results: We found that electronic TIL variables were associated with favorable prognosis in both the HPV-positive and -negative cases. After adjusting for clinicopathologic factors, Cox regression analysis demonstrated that electronic total TILs% (p = 0.025) in the HPV-positive and electronic stromal TILs% (p < 0.001) in the HPV-negative population were independent markers of disease specific outcomes (disease free survival).
Conclusions: Neural network TIL variables demonstrated independent prognostic value in validation cohorts of HPV-positive and HPV-negative head and neck cancers. These objective variables can be calculated by an open-source software and could be considered for testing in a prospective setting to assess potential clinical implications.
Keywords: Biomarker; HPV; Head and neck cancer; Prognosis; QuPath; TILs.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.J Natl Cancer Inst. 2022 Apr 11;114(4):609-617. doi: 10.1093/jnci/djab215. J Natl Cancer Inst. 2022. PMID: 34850048 Free PMC article.
-
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.Clin Cancer Res. 2021 Oct 15;27(20):5557-5565. doi: 10.1158/1078-0432.CCR-21-0325. Epub 2021 Jun 4. Clin Cancer Res. 2021. PMID: 34088723 Free PMC article.
-
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.Cancer Immunol Immunother. 2020 Oct;69(10):2089-2100. doi: 10.1007/s00262-020-02604-w. Epub 2020 May 24. Cancer Immunol Immunother. 2020. PMID: 32448984 Free PMC article.
-
Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.Acta Otolaryngol. 2020 Mar;140(3):246-248. doi: 10.1080/00016489.2020.1720284. Epub 2020 Feb 5. Acta Otolaryngol. 2020. PMID: 32022615 Review.
-
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.Cancer Immun. 2008 Dec 4;8:16. Cancer Immun. 2008. PMID: 19053167 Free PMC article. Review.
References
-
- Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical